India Leads Others In M&A Drug Maker Deals In Europe
This article was originally published in PharmAsia News
Executive Summary
India's pharmaceutical industry outpaced its global colleagues in conducting deals with European drug makers for the first eight months of this year. Through August, Indian drug makers made 109 deals considered mergers or acquisitions since 2005, with 56 percent of them involving European firms. The United Kingdom was the primary target of Indian M&As. But there is some concern a rising trend of protectionism in Europe could deter the expansion there in the future. (Click here for more
|
India's pharmaceutical industry outpaced its global colleagues in conducting deals with European drug makers for the first eight months of this year. Through August, Indian drug makers made 109 deals considered mergers or acquisitions since 2005, with 56 percent of them involving European firms. The United Kingdom was the primary target of Indian M&As. But there is some concern a rising trend of protectionism in Europe could deter the expansion there in the future. (Click here for more) "Pharma Cos Pop European Pill" - Economic Times (India) (10/2/08) |